Latest News
New Meds and Tech: Afrezza – Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes
Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and…
Featured Resources
Mission Alliance Partners
These organizations share similar missions and values to PES. Learn more about our Mission Alliance Partners, and find out how you can become one.
PLATINUM Mission Alliance Partners
GOLD Mission Alliance Partners

